J2305 HCPCS code: Injection, nitroglycerin, 5 mg
J2305 is the HCPCS Level II code for injection, nitroglycerin, 5 mg. In 2024 Medicare paid an average of $1.03 per service for J2305 across 716 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. Medicare volume fell 2% from 2023 to 2024 (729 to 716 services). In 2024, about 52 clinicians billed Medicare for J2305 for 397 beneficiaries; Florida, Texas, Maryland accounted for 78% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-07-01 |
| Last action effective | 2024-01-01 |
Who bills J2305 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 52 |
| Medicare beneficiaries | 397 |
| States with claims | 8 |
| Share of services in top 3 states (Florida, Texas, Maryland) | 78% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2305, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 729 | 163 | $1.27 | $1.01 |
| 2024 | 716 | 397 | $1.31 | $1.03 |
States with the most J2305 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 224 | $1.05 |
| Texas | 156 | $1.07 |
| Maryland | 54 | $1.04 |
| Minnesota | 54 | $1.08 |
| Ohio | 21 | $1.08 |
What changed for J2305
- 2023-07-01: J2305 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2305?
J2305 is the HCPCS Level II code for injection, nitroglycerin, 5 mg. Short descriptor: "Inj, nitroglycerin, 5 mg".
How much does Medicare pay for J2305?
In 2024, the average Medicare payment was $1.03 per service (average allowed $1.31).
Does Medicare cover J2305?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Related J23 codes
- J2300 — Injection, nalbuphine hydrochloride, per 10 mg
- J2310 — Injection, naloxone hydrochloride, per 1 mg
- J2311 — Injection, naloxone hydrochloride (zimhi), 1 mg
- J2312 — Injection, naloxone hydrochloride, not otherwise specified, 0.01 mg
- J2313 — Injection, naloxone hydrochloride (zimhi), 0.01 mg
- J2315 — Injection, naltrexone, depot form, 1 mg
- J2320 — Injection, nandrolone decanoate, up to 50 mg
- J2323 — Injection, natalizumab, 1 mg
- J2325 — Injection, nesiritide, 0.1 mg
- J2326 — Injection, nusinersen, 0.1 mg
- J2327 — Injection, risankizumab-rzaa, intravenous, 1 mg
- J2329 — Injection, ublituximab-xiiy, 1mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2305
- Watch J2305 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2305
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.